Filing Details
- Accession Number:
- 0001127602-14-034342
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-05 17:20:08
- Reporting Period:
- 2014-12-03
- Filing Date:
- 2014-12-05
- Accepted Time:
- 2014-12-05 17:20:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1577061 | Alfred Sandrock | Biogen Idec Inc. 225 Binney Street Cambridge MA 02142 | Grp Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-12-03 | 393 | $347.34 | 15,014 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-12-04 | 440 | $345.88 | 14,574 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.